Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT02513394
Registration number
NCT02513394
Ethics application status
Date submitted
29/07/2015
Date registered
31/07/2015
Date last updated
24/01/2024
Titles & IDs
Public title
PALbociclib CoLlaborative Adjuvant Study
Query!
Scientific title
PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer
Query!
Secondary ID [1]
0
0
ABCSG 42
Query!
Secondary ID [2]
0
0
AFT-05
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
PALLAS
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Breast Cancer
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Breast
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Experimental: Arm A - Palbociclib at a dose of 125 mg orally once daily, Day 1 to Day 21 followed by 7 days off treatment in a 28-day cycle for a total duration of 2 years, in addition to standard adjuvant endocrine therapy for a duration of at least 5 years.
Other: Arm B - Standard adjuvant endocrine therapy for a duration of at least 5 years.
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Invasive Disease Free Survival (iDFS)
Query!
Assessment method [1]
0
0
Invasive disease-free survival (iDFS) for the combination of at least 5 years endocrine therapy and 2-year palbociclib treatment versus at least 5 years endocrine therapy alone in patients with histologically confirmed HR+/HER2- invasive early breast cancer (EBC) at 4 years. iDFS is defined as the time from randomization to the date of the first event: local/regional invasive ipsilateral recurrence, contralateral invasive breast cancer, distant recurrence, second primary invasive cancer of non-breast origin or death from any cause. Direct comparison between arms used time to iDFS events and Kaplan-Meier Log-rank analysis. Due to the medians not yet achieved, the percentage of patients considered iDFS at 4 years is reported.
Query!
Timepoint [1]
0
0
4 years
Query!
Secondary outcome [1]
0
0
Invasive Disease Free Survival (iDFS) Excluding Second Primary Invasive Cancers of Non-breast Origin.
Query!
Assessment method [1]
0
0
Invasive disease-free survival (iDFS, excluding second primary invasive cancers of non-breast origin) for the combination of at least 5 years endocrine therapy and 2-year palbociclib treatment versus at least 5 years endocrine therapy alone in patients with histologically confirmed HR+/HER2- invasive early breast cancer (EBC) at 4 years. iDFS excluding second primary invasive cancers of non-breast origin is defined as the time from randomization to the date of the first event: local/regional invasive ipsilateral recurrence, contralateral invasive breast cancer, distant recurrence, or death from any cause. Second primary invasive cancers of non-breast origin will not be considered as events for this endpoint. Direct comparison between arms used time to iDFS events and Kaplan-Meier Log-rank analysis. Due to the medians not yet achieved, the percentage of patients considered iDFS at 4 years is reported.
Query!
Timepoint [1]
0
0
4 years
Query!
Secondary outcome [2]
0
0
Distant Recurrence-free Survival (DRFS)
Query!
Assessment method [2]
0
0
Compare time to distant recurrence-free survival (DRFS). Distant recurrence is defined according to STEEP criteria as the time from randomization to the date of the first event: distant recurrence or death from any cause. Patients with a locoregional recurrence will continue to be followed for DRFS. Surviving patients who are event-free will be censored at: the date of last disease assessment, or withdrawal of consent to be followed, or death whichever came first. Direct comparison between arms used time to DRFS events and Kaplan-Meier Log-rank analysis. Due to the medians not yet achieved, the percentage of patients considered DRFS at 4 years is reported.
Query!
Timepoint [2]
0
0
4 years
Query!
Secondary outcome [3]
0
0
Overall Survival (OS)
Query!
Assessment method [3]
0
0
Compare overall survival (OS). Overall survival is defined as the time period between randomization and death. Surviving patients classified as lost-to-follow up or having withdrawn consent to be followed will be censored at their date of last contact or withdrawal of consent to be followed, whichever occurs first.
Query!
Timepoint [3]
0
0
4 years
Query!
Secondary outcome [4]
0
0
Locoregional Recurrences-free Survival (LRRFS)
Query!
Assessment method [4]
0
0
Compare locoregional recurrence-free survival (LRRFS). LRRFS is defined as the time from randomization to the date of the first event: local/regional invasive ipsilateral recurrence, contralateral invasive breast cancer, or death from any cause. Patients with second primary invasive cancers of non-breast origin or distant recurrence will be censored at the date of diagnosis. Surviving patients who are event-free will be censored at: the date of last disease assessment, or withdrawal of consent to be followed, whichever occurs first.
Query!
Timepoint [4]
0
0
4 years
Query!
Eligibility
Key inclusion criteria
* Signed informed consent prior to study specific procedures.
* Age =18 years (or per national guidelines).
* Pre- and postmenopausal women or men with Stage II (Stage IIA limited to max. 1000 patients) or Stage III early invasive breast cancer
* Patients with multicentric and/or multifocal and/or bilateral early invasive breast cancer are eligible if all histopathologically examined tumors meet pathologic criteria for ER+ and/or PR+ and HER2-.
* Patients must have histologically confirmed ER+ and/or PR+, HER2-, early invasive breast cancer.
* Patients must have undergone adequate (definitive) breast surgery for the current malignancy.
FFPE tumor tissue block must be confirmed to be received at the central sample repository prior to randomization.
* ECOG performance status 0-1.
* Patients must be able and willing to swallow and retain oral medication.
* Serum or urine pregnancy test must be negative in premenopausal women within 14 days of randomization, or in women with amenorrhea of less than 12 months at time of randomization.
* Patients who received neo/adjuvant therapy must be after last dose of chemotherapy and/or biologic therapy and must have sufficient resolution of side effects.
* Patients who received breast/axilla/post-mastectomy chest wall radiotherapy must be after last dose of radiotherapy and must have sufficient resolution of side effects.
* Patients must have sufficient resolution of any surgical side effects (no active wound healing complications).
-Patients must either be initiating or have already started adjuvant hormonal treatment. -
* Patients who already received neo/adjuvant endocrine therapy are eligible as long as they are enrolled within 12 months of initial histological diagnosis and after completing no more than 6 months of adjuvant endocrine therapy.
* Absolute neutrophil count = 1,500/µL
* Platelets = 100,000/ mm3
* Hemoglobin = 10g/dL
* Total serum bilirubin = ULN; or total bilirubin = 3.0 × ULN with direct bilirubin within normal range in patients with documented Gilbert's Syndrome.
* Aspartate amino transferase (AST or SGOT) and alanine amino transferase (ALT or SGPT) = 1.5 × institutional ULN.
* Serum creatinine below the upper limit of the institutional normal range (ULN) or creatinine clearance = 60 mL/min/1.73 m2 for patients with serum creatinine levels above institutional ULN.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Concurrent therapy with other Investigational Products.
* Prior therapy with any CDK inhibitor.
* Patients with Stage I or IV breast cancer are not eligible.
* History of allergic reactions attributed to compounds of chemical or biologic composition similar to palbociclib.
* Patients receiving any medications or substances that are potent inhibitors or inducers of
* CYP3A isoenzymes within 7 days of randomization.
* Uncontrolled intercurrent illness that would limit compliance with study requirements.
* Pregnant women, or women of childbearing potential without a negative pregnancy test within 14 days prior to randomization.
* Patients with a history of any malignancy are ineligible
* Patients who previously received endocrine therapy within 5 years prior to diagnosis of the current malignancy.
* Patients on antiretroviral therapy.
* Patients with clinically significant history of any chronic liver disease.
* Patients receiving concurrent exogenous hormone therapy (topical vaginal estrogen therapy is allowable).
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/08/2015
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
1/09/2025
Query!
Actual
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
5796
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,TAS,VIC,WA
Query!
Recruitment hospital [1]
0
0
Southern Highlands Cancer Centre - Bowral
Query!
Recruitment hospital [2]
0
0
Coffs Harbour Health Campus - MNCCI - Coffs Harbour
Query!
Recruitment hospital [3]
0
0
The Breast & Endocrine Centre - Gateshead
Query!
Recruitment hospital [4]
0
0
Gosford Hospital - Gosford
Query!
Recruitment hospital [5]
0
0
Macquarie University Hospital - Macquarie Park
Query!
Recruitment hospital [6]
0
0
Orange Health Service - Orange
Query!
Recruitment hospital [7]
0
0
Wollongong Hospital - Wollongong
Query!
Recruitment hospital [8]
0
0
Royal Brisbane & Women's Hospital - Brisbane
Query!
Recruitment hospital [9]
0
0
Flinders Drive - Bedford Park
Query!
Recruitment hospital [10]
0
0
Royal Hobart Hospital - Hobart
Query!
Recruitment hospital [11]
0
0
The Northern Hospital - Epping
Query!
Recruitment hospital [12]
0
0
St Vincent's Hospital - Fitzroy
Query!
Recruitment hospital [13]
0
0
Peninsula Health - Frankston Hospital - Frankston
Query!
Recruitment hospital [14]
0
0
University Hospital, Geelong - Geelong
Query!
Recruitment hospital [15]
0
0
Peter MacCallum Cancer Centre - Melbourne
Query!
Recruitment hospital [16]
0
0
Peninsula Health - Frankston Hospital - Melbourne
Query!
Recruitment hospital [17]
0
0
Western Health, Sunshine Hospital - St. Albans
Query!
Recruitment hospital [18]
0
0
South West Healthcare, Warrnambool - Warrnambool
Query!
Recruitment hospital [19]
0
0
St John of God Bunbury Hospital - Bunbury
Query!
Recruitment hospital [20]
0
0
Fiona Stanley Hospital - Murdoch
Query!
Recruitment hospital [21]
0
0
Breast Cancer Research Centre - WA - Nedlands
Query!
Recruitment postcode(s) [1]
0
0
2576 - Bowral
Query!
Recruitment postcode(s) [2]
0
0
2450 - Coffs Harbour
Query!
Recruitment postcode(s) [3]
0
0
2290 - Gateshead
Query!
Recruitment postcode(s) [4]
0
0
2500 - Gosford
Query!
Recruitment postcode(s) [5]
0
0
2109 - Macquarie Park
Query!
Recruitment postcode(s) [6]
0
0
2800 - Orange
Query!
Recruitment postcode(s) [7]
0
0
2500 - Wollongong
Query!
Recruitment postcode(s) [8]
0
0
4029 - Brisbane
Query!
Recruitment postcode(s) [9]
0
0
5042 - Bedford Park
Query!
Recruitment postcode(s) [10]
0
0
7000 - Hobart
Query!
Recruitment postcode(s) [11]
0
0
3076 - Epping
Query!
Recruitment postcode(s) [12]
0
0
3065 - Fitzroy
Query!
Recruitment postcode(s) [13]
0
0
3199 - Frankston
Query!
Recruitment postcode(s) [14]
0
0
3220 - Geelong
Query!
Recruitment postcode(s) [15]
0
0
3000 - Melbourne
Query!
Recruitment postcode(s) [16]
0
0
- Melbourne
Query!
Recruitment postcode(s) [17]
0
0
3021 - St. Albans
Query!
Recruitment postcode(s) [18]
0
0
3280 - Warrnambool
Query!
Recruitment postcode(s) [19]
0
0
6231 - Bunbury
Query!
Recruitment postcode(s) [20]
0
0
- Murdoch
Query!
Recruitment postcode(s) [21]
0
0
6009 - Nedlands
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Alabama
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Alaska
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Arizona
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
California
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Colorado
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Connecticut
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Delaware
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
District of Columbia
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Florida
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Georgia
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Illinois
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Indiana
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Iowa
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Kentucky
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
Louisiana
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
Maine
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
Maryland
Query!
Country [18]
0
0
United States of America
Query!
State/province [18]
0
0
Massachusetts
Query!
Country [19]
0
0
United States of America
Query!
State/province [19]
0
0
Michigan
Query!
Country [20]
0
0
United States of America
Query!
State/province [20]
0
0
Minnesota
Query!
Country [21]
0
0
United States of America
Query!
State/province [21]
0
0
Missouri
Query!
Country [22]
0
0
United States of America
Query!
State/province [22]
0
0
Nebraska
Query!
Country [23]
0
0
United States of America
Query!
State/province [23]
0
0
New Hampshire
Query!
Country [24]
0
0
United States of America
Query!
State/province [24]
0
0
New Jersey
Query!
Country [25]
0
0
United States of America
Query!
State/province [25]
0
0
New Mexico
Query!
Country [26]
0
0
United States of America
Query!
State/province [26]
0
0
New York
Query!
Country [27]
0
0
United States of America
Query!
State/province [27]
0
0
North Carolina
Query!
Country [28]
0
0
United States of America
Query!
State/province [28]
0
0
Ohio
Query!
Country [29]
0
0
United States of America
Query!
State/province [29]
0
0
Oklahoma
Query!
Country [30]
0
0
United States of America
Query!
State/province [30]
0
0
Oregon
Query!
Country [31]
0
0
United States of America
Query!
State/province [31]
0
0
Pennsylvania
Query!
Country [32]
0
0
United States of America
Query!
State/province [32]
0
0
Rhode Island
Query!
Country [33]
0
0
United States of America
Query!
State/province [33]
0
0
South Carolina
Query!
Country [34]
0
0
United States of America
Query!
State/province [34]
0
0
South Dakota
Query!
Country [35]
0
0
United States of America
Query!
State/province [35]
0
0
Tennessee
Query!
Country [36]
0
0
United States of America
Query!
State/province [36]
0
0
Texas
Query!
Country [37]
0
0
United States of America
Query!
State/province [37]
0
0
Utah
Query!
Country [38]
0
0
United States of America
Query!
State/province [38]
0
0
Virginia
Query!
Country [39]
0
0
United States of America
Query!
State/province [39]
0
0
West Virginia
Query!
Country [40]
0
0
United States of America
Query!
State/province [40]
0
0
Wisconsin
Query!
Country [41]
0
0
Austria
Query!
State/province [41]
0
0
Feldkirch
Query!
Country [42]
0
0
Austria
Query!
State/province [42]
0
0
Graz
Query!
Country [43]
0
0
Austria
Query!
State/province [43]
0
0
Innsbruck
Query!
Country [44]
0
0
Austria
Query!
State/province [44]
0
0
Kufstein
Query!
Country [45]
0
0
Austria
Query!
State/province [45]
0
0
Leoben
Query!
Country [46]
0
0
Austria
Query!
State/province [46]
0
0
Linz
Query!
Country [47]
0
0
Austria
Query!
State/province [47]
0
0
Mistelbach
Query!
Country [48]
0
0
Austria
Query!
State/province [48]
0
0
Ried
Query!
Country [49]
0
0
Austria
Query!
State/province [49]
0
0
Salzburg
Query!
Country [50]
0
0
Austria
Query!
State/province [50]
0
0
St. Pölten
Query!
Country [51]
0
0
Austria
Query!
State/province [51]
0
0
St. Veit an der Glan
Query!
Country [52]
0
0
Austria
Query!
State/province [52]
0
0
Steyr
Query!
Country [53]
0
0
Austria
Query!
State/province [53]
0
0
Vienna
Query!
Country [54]
0
0
Austria
Query!
State/province [54]
0
0
Voecklabruck
Query!
Country [55]
0
0
Austria
Query!
State/province [55]
0
0
Weiz
Query!
Country [56]
0
0
Austria
Query!
State/province [56]
0
0
Wels
Query!
Country [57]
0
0
Austria
Query!
State/province [57]
0
0
Wolfsberg
Query!
Country [58]
0
0
Austria
Query!
State/province [58]
0
0
Wr. Neustadt
Query!
Country [59]
0
0
Belgium
Query!
State/province [59]
0
0
Aalst
Query!
Country [60]
0
0
Belgium
Query!
State/province [60]
0
0
Brussels
Query!
Country [61]
0
0
Belgium
Query!
State/province [61]
0
0
Bruxelles
Query!
Country [62]
0
0
Belgium
Query!
State/province [62]
0
0
Charleroi
Query!
Country [63]
0
0
Belgium
Query!
State/province [63]
0
0
Edegem
Query!
Country [64]
0
0
Belgium
Query!
State/province [64]
0
0
Leuven
Query!
Country [65]
0
0
Belgium
Query!
State/province [65]
0
0
Liège
Query!
Country [66]
0
0
Belgium
Query!
State/province [66]
0
0
Namur
Query!
Country [67]
0
0
Belgium
Query!
State/province [67]
0
0
Verviers
Query!
Country [68]
0
0
Belgium
Query!
State/province [68]
0
0
Wilrijk
Query!
Country [69]
0
0
Canada
Query!
State/province [69]
0
0
Alberta
Query!
Country [70]
0
0
Canada
Query!
State/province [70]
0
0
British Columbia
Query!
Country [71]
0
0
Canada
Query!
State/province [71]
0
0
Manitoba
Query!
Country [72]
0
0
Canada
Query!
State/province [72]
0
0
New Brunswick
Query!
Country [73]
0
0
Canada
Query!
State/province [73]
0
0
Nova Scotia
Query!
Country [74]
0
0
Canada
Query!
State/province [74]
0
0
Ontario
Query!
Country [75]
0
0
Canada
Query!
State/province [75]
0
0
Quebec
Query!
Country [76]
0
0
Canada
Query!
State/province [76]
0
0
Saskatchewan
Query!
Country [77]
0
0
Germany
Query!
State/province [77]
0
0
Aachen
Query!
Country [78]
0
0
Germany
Query!
State/province [78]
0
0
Berlin
Query!
Country [79]
0
0
Germany
Query!
State/province [79]
0
0
Bottrop
Query!
Country [80]
0
0
Germany
Query!
State/province [80]
0
0
Braunschweig
Query!
Country [81]
0
0
Germany
Query!
State/province [81]
0
0
Ebersberg
Query!
Country [82]
0
0
Germany
Query!
State/province [82]
0
0
Eggenfelden
Query!
Country [83]
0
0
Germany
Query!
State/province [83]
0
0
Erlangen
Query!
Country [84]
0
0
Germany
Query!
State/province [84]
0
0
Frankfurt
Query!
Country [85]
0
0
Germany
Query!
State/province [85]
0
0
Fürth
Query!
Country [86]
0
0
Germany
Query!
State/province [86]
0
0
Halle (Saale)
Query!
Country [87]
0
0
Germany
Query!
State/province [87]
0
0
Hamburg
Query!
Country [88]
0
0
Germany
Query!
State/province [88]
0
0
Karlsruhe
Query!
Country [89]
0
0
Germany
Query!
State/province [89]
0
0
Kassel
Query!
Country [90]
0
0
Germany
Query!
State/province [90]
0
0
Leipzig
Query!
Country [91]
0
0
Germany
Query!
State/province [91]
0
0
Limburg
Query!
Country [92]
0
0
Germany
Query!
State/province [92]
0
0
Lübeck
Query!
Country [93]
0
0
Germany
Query!
State/province [93]
0
0
Mainz
Query!
Country [94]
0
0
Germany
Query!
State/province [94]
0
0
München
Query!
Country [95]
0
0
Germany
Query!
State/province [95]
0
0
Oldenburg
Query!
Country [96]
0
0
Germany
Query!
State/province [96]
0
0
Recklinghausen
Query!
Country [97]
0
0
Germany
Query!
State/province [97]
0
0
Rottweil
Query!
Country [98]
0
0
Germany
Query!
State/province [98]
0
0
Wiesbaden
Query!
Country [99]
0
0
Hungary
Query!
State/province [99]
0
0
Budapest
Query!
Country [100]
0
0
Hungary
Query!
State/province [100]
0
0
Debrecen
Query!
Country [101]
0
0
Hungary
Query!
State/province [101]
0
0
Gyor
Query!
Country [102]
0
0
Hungary
Query!
State/province [102]
0
0
Szeged
Query!
Country [103]
0
0
Ireland
Query!
State/province [103]
0
0
Cork
Query!
Country [104]
0
0
Ireland
Query!
State/province [104]
0
0
Dublin
Query!
Country [105]
0
0
Ireland
Query!
State/province [105]
0
0
Limerick
Query!
Country [106]
0
0
Ireland
Query!
State/province [106]
0
0
Sligo
Query!
Country [107]
0
0
Ireland
Query!
State/province [107]
0
0
Waterford
Query!
Country [108]
0
0
Israel
Query!
State/province [108]
0
0
Central
Query!
Country [109]
0
0
Israel
Query!
State/province [109]
0
0
Tel Aviv
Query!
Country [110]
0
0
Israel
Query!
State/province [110]
0
0
Tel-Aviv
Query!
Country [111]
0
0
Italy
Query!
State/province [111]
0
0
Ferrara
Query!
Country [112]
0
0
Italy
Query!
State/province [112]
0
0
Florence
Query!
Country [113]
0
0
Italy
Query!
State/province [113]
0
0
Genoa
Query!
Country [114]
0
0
Italy
Query!
State/province [114]
0
0
Grosseto
Query!
Country [115]
0
0
Italy
Query!
State/province [115]
0
0
Legnago
Query!
Country [116]
0
0
Italy
Query!
State/province [116]
0
0
Meldola
Query!
Country [117]
0
0
Italy
Query!
State/province [117]
0
0
Milano
Query!
Country [118]
0
0
Italy
Query!
State/province [118]
0
0
Monza
Query!
Country [119]
0
0
Italy
Query!
State/province [119]
0
0
Parma
Query!
Country [120]
0
0
Italy
Query!
State/province [120]
0
0
Prato
Query!
Country [121]
0
0
Italy
Query!
State/province [121]
0
0
Treviglio
Query!
Country [122]
0
0
Italy
Query!
State/province [122]
0
0
Turin
Query!
Country [123]
0
0
Japan
Query!
State/province [123]
0
0
Aichi
Query!
Country [124]
0
0
Japan
Query!
State/province [124]
0
0
Hokkaido
Query!
Country [125]
0
0
Japan
Query!
State/province [125]
0
0
Chiba
Query!
Country [126]
0
0
Japan
Query!
State/province [126]
0
0
Kyoto
Query!
Country [127]
0
0
Japan
Query!
State/province [127]
0
0
Osaka
Query!
Country [128]
0
0
Korea, Republic of
Query!
State/province [128]
0
0
Seoul
Query!
Country [129]
0
0
Mexico
Query!
State/province [129]
0
0
Nuevo León
Query!
Country [130]
0
0
Mexico
Query!
State/province [130]
0
0
Toluca
Query!
Country [131]
0
0
Mexico
Query!
State/province [131]
0
0
Mexico City
Query!
Country [132]
0
0
Netherlands
Query!
State/province [132]
0
0
Den Haag
Query!
Country [133]
0
0
Netherlands
Query!
State/province [133]
0
0
Eindhoven
Query!
Country [134]
0
0
Netherlands
Query!
State/province [134]
0
0
Geleen
Query!
Country [135]
0
0
Netherlands
Query!
State/province [135]
0
0
Nieuwegein
Query!
Country [136]
0
0
Netherlands
Query!
State/province [136]
0
0
Zaandam
Query!
Country [137]
0
0
Netherlands
Query!
State/province [137]
0
0
Zwolle
Query!
Country [138]
0
0
Poland
Query!
State/province [138]
0
0
Gdansk
Query!
Country [139]
0
0
Poland
Query!
State/province [139]
0
0
Opole
Query!
Country [140]
0
0
Poland
Query!
State/province [140]
0
0
Warsaw
Query!
Country [141]
0
0
Poland
Query!
State/province [141]
0
0
Lódz
Query!
Country [142]
0
0
Portugal
Query!
State/province [142]
0
0
Lisboa
Query!
Country [143]
0
0
Portugal
Query!
State/province [143]
0
0
Lisbon
Query!
Country [144]
0
0
Portugal
Query!
State/province [144]
0
0
Porto
Query!
Country [145]
0
0
Spain
Query!
State/province [145]
0
0
A Coruña
Query!
Country [146]
0
0
Spain
Query!
State/province [146]
0
0
Alicante
Query!
Country [147]
0
0
Spain
Query!
State/province [147]
0
0
Badalona
Query!
Country [148]
0
0
Spain
Query!
State/province [148]
0
0
Barcelona
Query!
Country [149]
0
0
Spain
Query!
State/province [149]
0
0
Burgos
Query!
Country [150]
0
0
Spain
Query!
State/province [150]
0
0
Castellón De La Plana
Query!
Country [151]
0
0
Spain
Query!
State/province [151]
0
0
Cáceres
Query!
Country [152]
0
0
Spain
Query!
State/province [152]
0
0
Córdoba
Query!
Country [153]
0
0
Spain
Query!
State/province [153]
0
0
Elche
Query!
Country [154]
0
0
Spain
Query!
State/province [154]
0
0
Girona
Query!
Country [155]
0
0
Spain
Query!
State/province [155]
0
0
León
Query!
Country [156]
0
0
Spain
Query!
State/province [156]
0
0
Madrid
Query!
Country [157]
0
0
Spain
Query!
State/province [157]
0
0
Murcia
Query!
Country [158]
0
0
Spain
Query!
State/province [158]
0
0
Málaga
Query!
Country [159]
0
0
Spain
Query!
State/province [159]
0
0
Oviedo
Query!
Country [160]
0
0
Spain
Query!
State/province [160]
0
0
Palma
Query!
Country [161]
0
0
Spain
Query!
State/province [161]
0
0
Pamplona
Query!
Country [162]
0
0
Spain
Query!
State/province [162]
0
0
Reus
Query!
Country [163]
0
0
Spain
Query!
State/province [163]
0
0
San Sebastián
Query!
Country [164]
0
0
Spain
Query!
State/province [164]
0
0
Sant Joan Despì
Query!
Country [165]
0
0
Spain
Query!
State/province [165]
0
0
Santiago
Query!
Country [166]
0
0
Spain
Query!
State/province [166]
0
0
Sevilla
Query!
Country [167]
0
0
Spain
Query!
State/province [167]
0
0
Terrassa
Query!
Country [168]
0
0
Spain
Query!
State/province [168]
0
0
Toledo
Query!
Country [169]
0
0
Spain
Query!
State/province [169]
0
0
Valencia
Query!
Country [170]
0
0
Spain
Query!
State/province [170]
0
0
Zaragoza
Query!
Country [171]
0
0
Sweden
Query!
State/province [171]
0
0
Gävle
Query!
Country [172]
0
0
Sweden
Query!
State/province [172]
0
0
Göteborg
Query!
Country [173]
0
0
Sweden
Query!
State/province [173]
0
0
Stockholm
Query!
Country [174]
0
0
Sweden
Query!
State/province [174]
0
0
Uppsala
Query!
Country [175]
0
0
Sweden
Query!
State/province [175]
0
0
Örebro
Query!
Country [176]
0
0
Switzerland
Query!
State/province [176]
0
0
Aargau
Query!
Country [177]
0
0
Switzerland
Query!
State/province [177]
0
0
Bern
Query!
Country [178]
0
0
Switzerland
Query!
State/province [178]
0
0
Geneva
Query!
Country [179]
0
0
Switzerland
Query!
State/province [179]
0
0
Graubünden
Query!
Country [180]
0
0
Switzerland
Query!
State/province [180]
0
0
Tessin
Query!
Country [181]
0
0
Switzerland
Query!
State/province [181]
0
0
Basel
Query!
Country [182]
0
0
Switzerland
Query!
State/province [182]
0
0
Fribourg
Query!
Country [183]
0
0
Switzerland
Query!
State/province [183]
0
0
Luzern
Query!
Country [184]
0
0
Switzerland
Query!
State/province [184]
0
0
St.Gallen
Query!
Country [185]
0
0
Switzerland
Query!
State/province [185]
0
0
Zurich
Query!
Country [186]
0
0
Taiwan
Query!
State/province [186]
0
0
Changhua County
Query!
Country [187]
0
0
Taiwan
Query!
State/province [187]
0
0
Kaohsiung
Query!
Country [188]
0
0
Taiwan
Query!
State/province [188]
0
0
Tainan
Query!
Country [189]
0
0
Taiwan
Query!
State/province [189]
0
0
Taipei
Query!
Country [190]
0
0
United Kingdom
Query!
State/province [190]
0
0
Birmingham
Query!
Country [191]
0
0
United Kingdom
Query!
State/province [191]
0
0
Bristol
Query!
Country [192]
0
0
United Kingdom
Query!
State/province [192]
0
0
Cardiff
Query!
Country [193]
0
0
United Kingdom
Query!
State/province [193]
0
0
Chelsea
Query!
Country [194]
0
0
United Kingdom
Query!
State/province [194]
0
0
Glasgow
Query!
Country [195]
0
0
United Kingdom
Query!
State/province [195]
0
0
Leicester
Query!
Country [196]
0
0
United Kingdom
Query!
State/province [196]
0
0
Liverpool
Query!
Country [197]
0
0
United Kingdom
Query!
State/province [197]
0
0
London
Query!
Country [198]
0
0
United Kingdom
Query!
State/province [198]
0
0
Maidstone
Query!
Country [199]
0
0
United Kingdom
Query!
State/province [199]
0
0
Manchester
Query!
Country [200]
0
0
United Kingdom
Query!
State/province [200]
0
0
Newcastle upon Tyne
Query!
Country [201]
0
0
United Kingdom
Query!
State/province [201]
0
0
Nottingham
Query!
Country [202]
0
0
United Kingdom
Query!
State/province [202]
0
0
Sheffield
Query!
Country [203]
0
0
United Kingdom
Query!
State/province [203]
0
0
Truro
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Alliance Foundation Trials, LLC.
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Other
Query!
Name [1]
0
0
Austrian Breast & Colorectal Cancer Study Group
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Other collaborator category [2]
0
0
Other
Query!
Name [2]
0
0
NSABP Foundation Inc
Query!
Address [2]
0
0
Query!
Country [2]
0
0
Query!
Other collaborator category [3]
0
0
Other
Query!
Name [3]
0
0
PrECOG, LLC.
Query!
Address [3]
0
0
Query!
Country [3]
0
0
Query!
Other collaborator category [4]
0
0
Other
Query!
Name [4]
0
0
Breast International Group
Query!
Address [4]
0
0
Query!
Country [4]
0
0
Query!
Other collaborator category [5]
0
0
Commercial sector/industry
Query!
Name [5]
0
0
Pfizer
Query!
Address [5]
0
0
Query!
Country [5]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This is a prospective, two arm, international, multicenter, randomized, open-label Phase III study evaluating the addition of 2 years of palbociclib to standard adjuvant endocrine therapy for patients with HR+ / HER2- early breast cancer (EBC). The purpose of the PALLAS study is to determine whether the addition of palbociclib to adjuvant endocrine therapy will improve outcomes over endocrine therapy alone for HR+/HER2- early breast cancer. Assessment of a variety of correlative analysis, including evaluation of the effect of palbociclib in genomically defined tumor subgroups, is planned.
Query!
Trial website
https://clinicaltrials.gov/study/NCT02513394
Query!
Trial related presentations / publications
Mayer EL, Fesl C, Hlauschek D, Garcia-Estevez L, Burstein HJ, Zdenkowski N, Wette V, Miller KD, Balic M, Mayer IA, Cameron D, Winer EP, Ponce Lorenzo JJ, Lake D, Pristauz-Telsnigg G, Haddad TC, Shepherd L, Iwata H, Goetz M, Cardoso F, Traina TA, Sabanathan D, Breitenstein U, Ackerl K, Metzger Filho O, Zehetner K, Solomon K, El-Abed S, Theall KP, Lu DR, Dueck A, Gnant M, DeMichele A. Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03). J Clin Oncol. 2022 Feb 10;40(5):449-458. doi: 10.1200/JCO.21.01918. Epub 2022 Jan 7. Gnant M, Dueck AC, Frantal S, Martin M, Burstein HJ, Greil R, Fox P, Wolff AC, Chan A, Winer EP, Pfeiler G, Miller KD, Colleoni M, Suga JM, Rubovsky G, Bliss JM, Mayer IA, Singer CF, Nowecki Z, Hahn O, Thomson J, Wolmark N, Amillano K, Rugo HS, Steger GG, Hernando Fernandez de Aranguiz B, Haddad TC, Perello A, Bellet M, Fohler H, Metzger Filho O, Jallitsch-Halper A, Solomon K, Schurmans C, Theall KP, Lu DR, Tenner K, Fesl C, DeMichele A, Mayer EL; PALLAS groups and investigators. Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03). J Clin Oncol. 2022 Jan 20;40(3):282-293. doi: 10.1200/JCO.21.02554. Epub 2021 Dec 7. Mayer EL, Dueck AC, Martin M, Rubovszky G, Burstein HJ, Bellet-Ezquerra M, Miller KD, Zdenkowski N, Winer EP, Pfeiler G, Goetz M, Ruiz-Borrego M, Anderson D, Nowecki Z, Loibl S, Moulder S, Ring A, Fitzal F, Traina T, Chan A, Rugo HS, Lemieux J, Henao F, Lyss A, Antolin Novoa S, Wolff AC, Vetter M, Egle D, Morris PG, Mamounas EP, Gil-Gil MJ, Prat A, Fohler H, Metzger Filho O, Schwarz M, DuFrane C, Fumagalli D, Theall KP, Lu DR, Bartlett CH, Koehler M, Fesl C, DeMichele A, Gnant M. Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 2021 Feb;22(2):212-222. doi: 10.1016/S1470-2045(20)30642-2. Epub 2021 Jan 15. Dieras V, Rugo HS, Schnell P, Gelmon K, Cristofanilli M, Loi S, Colleoni M, Lu DR, Mori A, Gauthier E, Huang Bartlett C, Slamon DJ, Turner NC, Finn RS. Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer. J Natl Cancer Inst. 2019 Apr 1;111(4):419-430. doi: 10.1093/jnci/djy109.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Evanthia Galanis, MD
Query!
Address
0
0
Alliance Foundation Trials, LLC.
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Type
Other Details
Attachment
Study protocol
Study Protocol and Statistical Analysis Plan
https://cdn.clinicaltrials.gov/large-docs/94/NCT02513394/Prot_SAP_000.pdf
Statistical analysis plan
Study Protocol and Statistical Analysis Plan
https://cdn.clinicaltrials.gov/large-docs/94/NCT02513394/Prot_SAP_000.pdf
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results are available at
https://clinicaltrials.gov/study/NCT02513394
Download to PDF